Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Synthes said today it inked a purchase and development deal with Interventional Spine to pick up its expandable cages designed for minimally invasive spinal fusion surgeries. The newly acquired implants are designed for optimal tactile feedback and feature a continuously adjustable design to allow for height to be customized to the patient’s anatomy, […]
Ex-ConMed exec is Interventional Spine’s new Darling | Personnel Moves
Interventional Spine said it has tagged ex-ConMed executive and 25-year medical veteran Joseph Darling as its new vice president and COO. Darling spent 7 years with ConMed, serving as the COO, executive veep and prez of ConMed Linvatec until February this year. Before his time at ConMed, Darling worked with Smith & Nephew, Wyeth-Ayerst Pharmaceuticals, Baxter […]
Interventional Spine wins expanded clearance for Opticage spine implant
Interventional Spine said it secured expanded 510(k) clearance from the FDA for its Opticage spine implant
The Irvine, Calif.-based company makes implants used in spine surgeries, with a focus on osteoporosis-afflicted bones. expandable interbody fusion device.
Boston Scientific lauds NICE results from the U.K. | Regulatory Roundup
Boston Scientific Corp. (NYSE:BSX) lauded a new guidance released by the research arm of the U.K.’s National Health Service, the country’s publicly funded health care system.
The National Institute for Health & Clinical Excellence issued a final guidance for bronchial thermoplasty as an option for patients with severe asthma that isn’t controllable with drugs, a boon for Boston Scientific’s Alair.
MassDevice Network
@MassDevice
LinkedIn
YouTube